The retail market of ophthalmic drugs is stable and changing

"The eyes are the windows of the

Eighty percent of the market share is divided among the three categories, and the market is stable and changing

According to data from Mi Nei.

Percentage and changes of Chinese and Western medicines used in terminal ophthalmology in physical pharmacies in cities in China from 2018 to 2020

Source: Mi Nei.

In terms of dosage form, due to the particularity of the ocular structure, systemic administration cannot reach the ocular lesions in a timely and effective manner.

Distribution of terminal ophthalmic pharmacies in physical pharmacies in Chinese cities in 2020

Source: Mi Nei.

In terms of categories, anti-fatigue and dry drugs, anti-infective and anti-inflammatory drugs, and cataract drugs account for a relatively large proportion of ophthalmic drugs, with a total market share of more than 80%

Proportions and changes in the main categories of ophthalmic drugs used in physical pharmacies in cities in China from 2018 to 2020

Source: Mi Nei.

The anti-fatigue and dryness drug market continues to rise, with the growth rate of sodium hyaluronate and pearl improving eyesight leading the way

Modern society is an information society.

2018-2020 China's urban physical pharmacies anti-fatigue dry medicine market size and growth rate

Source: Mi Nei.

Meinenet data shows that among the top five types of anti-fatigue dry drugs in the retail market, the three-year compound growth rate of sodium hyaluronate and pearl bright eyes have maintained a double-digit growth rate

2018-2020 market share of TOP5 anti-fatigue dry drugs in Chinese urban physical pharmacies

Source: Mi Nei.

The cataract drug market is gradually shrinking, and the former "magic drug" has fallen from the altar

Cataract is a common ophthalmological disease characterized by opacity of the lens of the eye due to various reasons and the inability to form a clear image on the retina.

According to data from Mi Nei.

2018-2020 China's urban physical pharmacy terminal cataract drug market size and growth rate

Source: Mi Nei.

Among the TOP10 brands of cataract drugs, the bental lysine eye drops, which represents the drug Shapuaisi, saw sales drop by nearly 50% in 2020, directly "cut in the middle"

2020 China's urban physical pharmacies terminal cataract drug brands TOP10

Note: Chinese patent medicine for cataract has multiple indications

Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

The anti-infection and anti-inflammatory market remains stable, but the varieties have changed significantly

Due to the special structure of the eyes and the deteriorating external environment today, air suspensions such as bacteria and microorganisms are more likely to invade the eyes, causing symptoms of infection in the eyes
.
Anti-infective and anti-inflammatory drugs are mainly sold in hospitals.
In recent years, the sales of physical pharmacies in Chinese cities have remained at around 1.
2 billion yuan.
The CAGR from 2018 to 2020 is 1.
8%, and the performance is relatively stable
.

Among the top five types of anti-infective and anti-inflammatory drugs in the retail market, the market share of levofloxacin and erythromycin continues to increase
.
Since 2018, levofloxacin has surpassed ofloxacin to become the largest variety of anti-infective and anti-inflammatory drugs
.
Levofloxacin is the levofloxacin isomer of ofloxacin.
It belongs to the third-generation broad-spectrum fluoroquinolone antibacterial drug.
Its antibacterial activity is about twice that of ofloxacin.
It has the characteristics of broad antibacterial spectrum and strong antibacterial effect.
Consumer approval
.
Erythromycin has grown well in recent years, and its market share in 2020 is approaching that of ofloxacin, which ranks second
.
Erythromycin is a low-priced drug.
As the country liberalizes the price limit of low-priced drugs, the continuous price increase of the product has led to a continuous increase in sales
.

2018-2020 China's urban physical pharmacies terminal anti-infective and anti-inflammatory drugs market size and growth rate

Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

2017-2020 China's urban physical pharmacies terminal anti-infective and anti-inflammatory drugs TOP5 market share

Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern

Although the proportion of ophthalmic drugs in the retail market is small, with the intensification of aging and long-term overuse of eyes, the ophthalmic drugs market will show a trend of "small areas, big development", and market competition will become increasingly fierce.
If an enterprise wants to get a share of the pie, it will not only test the strength and influence of the brand, but also need to cater to the development of the times, and use digital emerging technologies to promote the transformation of traditional pharmaceutical marketing models in order to win the opportunity
.

Note: China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 prefectures and cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.